BSE - Delayed Quote INR
Ajanta Pharma Limited (AJANTPHARM.BO)
2,677.20
-108.85
(-3.91%)
At close: April 25 at 3:59:25 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
7,850,700
7,921,100
5,617,100
5,763,100
Investing Cash Flow
--
653,900
-5,596,000
-741,000
-2,823,800
Financing Cash Flow
--
-10,510,600
-1,082,000
-4,597,100
-3,182,900
End Cash Position
--
1,292,300
3,306,700
2,054,100
1,779,900
Capital Expenditure
--
-1,524,100
-1,744,900
-1,488,400
-1,716,100
Issuance of Debt
--
--
--
2,300
--
Repayment of Debt
--
--
-4,900
--
--
Repurchase of Capital Stock
--
-3,891,900
-14,400
-2,855,900
-1,354,100
Free Cash Flow
--
6,326,600
6,176,200
4,128,700
4,047,000
3/31/2021 - 6/5/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade